HCPCS codes:Q

• Q0035 - Cardiokymography.
• Q0081 - Infusion therapy, using other than chemotherapeutic drugs, per visit.
• Q0083 - Chemotherapy administration by other than infusion technique only (e.g., subcutaneous, intramuscular, push), per visit.
• Q0084 - Chemotherapy administration by infusion technique only, per visit.
• Q0085 - Chemotherapy administration by both infusion technique and other technique(s) (e.g., subcutaneous, intramuscular, push), per visit.
• Q0091 - Screening papanicolaou smear; obtaining, preparing and conveyance of cervical or vaginal smear to laboratory.
• Q0092 - Set-up portable x-ray equipment.
• Q0111 - Wet mounts, including preparations of vaginal, cervical or skin specimens.
• Q0112 - All potassium hydroxide (koh) preparations.
• Q0113 - Pinworm examinations.
• Q0114 - Fern test.
• Q0115 - Post-coital direct, qualitative examinations of vaginal or cervical mucous.
• Q0138 - Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use).
• Q0139 - Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (for esrd on dialysis).
• Q0144 - Azithromycin dihydrate, oral, capsules-powder, 1 gram.
• Q0161 - Chlorpromazine hydrochloride, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0162 - Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0163 - Diphenhydramine hydrochloride, 50 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at time of chemotherapy treatment not to exceed a 48 hour dosage regimen.
• Q0164 - Prochlorperazine maleate, 5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0166 - Granisetron hydrochloride, 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen.
• Q0167 - Dronabinol, 2.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0169 - Promethazine hydrochloride, 12.5 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0173 - Trimethobenzamide hydrochloride, 250 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0174 - Thiethylperazine maleate, 10 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0175 - Perphenazine, 4 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0177 - Hydroxyzine pamoate, 25 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0180 - Dolasetron mesylate, 100 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 24 hour dosage regimen.
• Q0181 - Unspecified oral dosage form, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for a iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen.
• Q0477 - Power module patient cable for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0478 - Power adapter for use with electric or electric-pneumatic ventricular assist device, vehicle type.
• Q0479 - Power module for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0480 - Driver for use with pneumatic ventricular assist device, replacement only.
• Q0481 - Microprocessor control unit for use with electric ventricular assist device, replacement only.
• Q0482 - Microprocessor control unit for use with electric-pneumatic combination ventricular assist device, replacement only.
• Q0483 - Monitor-display module for use with electric ventricular assist device, replacement only.
• Q0484 - Monitor-display module for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0485 - Monitor control cable for use with electric ventricular assist device, replacement only.
• Q0486 - Monitor control cable for use with electric-pneumatic ventricular assist device, replacement only.
• Q0487 - Leads (pneumatic-electrical) for use with any type electric-pneumatic ventricular assist device, replacement only.
• Q0488 - Power pack base for use with electric ventricular assist device, replacement only.
• Q0489 - Power pack base for use with electric-pneumatic ventricular assist device, replacement only.
• Q0490 - Emergency power source for use with electric ventricular assist device, replacement only.
• Q0491 - Emergency power source for use with electric-pneumatic ventricular assist device, replacement only.
• Q0492 - Emergency power supply cable for use with electric ventricular assist device, replacement only.
• Q0493 - Emergency power supply cable for use with electric-pneumatic ventricular assist device, replacement only.
• Q0494 - Emergency hand pump for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0495 - Battery-power pack charger for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0496 - Battery, other than lithium-ion, for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0497 - Battery clips for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0498 - Holster for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0499 - Belt-vest-bag for use to carry external peripheral components of any type ventricular assist device, replacement only.
• Q0500 - Filters for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0501 - Shower cover for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0502 - Mobility cart for pneumatic ventricular assist device, replacement only.
• Q0503 - Battery for pneumatic ventricular assist device, replacement only, each.
• Q0504 - Power adapter for pneumatic ventricular assist device, replacement only, vehicle type.
• Q0506 - Battery, lithium-ion, for use with electric or electric-pneumatic ventricular assist device, replacement only.
• Q0507 - Miscellaneous supply or accessory for use with an external ventricular assist device.
• Q0508 - Miscellaneous supply or accessory for use with an implanted ventricular assist device.
• Q0509 - Miscellaneous supply or accessory for use with any implanted ventricular assist device for which payment was not made under medicare part a.
• Q0510 - Pharmacy supply fee for initial immunosuppressive drug(s), first month following transplant.
• Q0511 - Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period.
• Q0512 - Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period.
• Q0513 - Pharmacy dispensing fee for inhalation drug(s); per 30 days.
• Q0514 - Pharmacy dispensing fee for inhalation drug(s); per 90 days.
• Q0515 - Injection, sermorelin acetate, 1 microgram.
• Q0 - Investigational clinical service provided in a clinical research study that is in an approved clinical research study.
• Q1004 - New technology intraocular lens category 4 as defined in federal register notice.
• Q1005 - New technology intraocular lens category 5 as defined in federal register notice.
• Q1 - Routine clinical service provided in a clinical research study that is in an approved clinical research study.
• Q2004 - Irrigation solution for treatment of bladder calculi, for example renacidin, per 500 ml.
• Q2009 - Injection, fosphenytoin, 50 mg phenytoin equivalent.
• Q2017 - Injection, teniposide, 50 mg.
• Q2026 - Injection, radiesse, 0.1 ml.
• Q2028 - Injection, sculptra, 0.5 mg.
• Q2034 - Influenza virus vaccine, split virus, for intramuscular use (agriflu).
• Q2035 - Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (afluria).
• Q2036 - Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (flulaval).
• Q2037 - Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluvirin).
• Q2038 - Influenza virus vaccine, split virus, when administered to individuals 3 years of age and older, for intramuscular use (fluzone).
• Q2039 - Influenza virus vaccine, not otherwise specified.
• Q2040 - Tisagenlecleucel, up to 250 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per infusion.
• Q2041 - Axicabtagene ciloleucel, up to 200 million autologous anti-cd19 car positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose.
• Q2042 - Tisagenlecleucel, up to 600 million car-positive viable t cells, including leukapheresis and dose preparation procedures, per therapeutic dose.
• Q2043 - Sipuleucel-t, minimum of 50 million autologous cd54+ cells activated with pap-gm-csf, including leukapheresis and all other preparatory procedures, per infusion.
• Q2049 - Injection, doxorubicin hydrochloride, liposomal, imported lipodox, 10 mg.
• Q2050 - Injection, doxorubicin hydrochloride, liposomal, not otherwise specified, 10 mg.
• Q2052 - Services, supplies and accessories used in the home under the medicare intravenous immune globulin (ivig) demonstration.
• Q2 - Demonstration procedure-service.
• Q3001 - Radioelements for brachytherapy, any type, each.
• Q3014 - Telehealth originating site facility fee.
• Q3027 - Injection, interferon beta-1a, 1 mcg for intramuscular use.
• Q3028 - Injection, interferon beta-1a, 1 mcg for subcutaneous use.
• Q3031 - Collagen skin test.
• Q3 - Live kidney donor surgery and related services.
• Q4001 - Casting supplies, body cast adult, with or without head, plaster.
• Q4002 - Cast supplies, body cast adult, with or without head, fiberglass.
• Q4003 - Cast supplies, shoulder cast, adult (11 years +), plaster.
• Q4004 - Cast supplies, shoulder cast, adult (11 years +), fiberglass.
• Q4005 - Cast supplies, long arm cast, adult (11 years +), plaster.
• Q4006 - Cast supplies, long arm cast, adult (11 years +), fiberglass.
• Q4007 - Cast supplies, long arm cast, pediatric (0-10 years), plaster.
• Q4008 - Cast supplies, long arm cast, pediatric (0-10 years), fiberglass.
• Q4009 - Cast supplies, short arm cast, adult (11 years +), plaster.
• Q4010 - Cast supplies, short arm cast, adult (11 years +), fiberglass.
• Q4011 - Cast supplies, short arm cast, pediatric (0-10 years), plaster.
• Q4012 - Cast supplies, short arm cast, pediatric (0-10 years), fiberglass.
• Q4013 - Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), plaster.
• Q4014 - Cast supplies, gauntlet cast (includes lower forearm and hand), adult (11 years +), fiberglass.
• Q4015 - Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), plaster.
• Q4016 - Cast supplies, gauntlet cast (includes lower forearm and hand), pediatric (0-10 years), fiberglass.
• Q4017 - Cast supplies, long arm splint, adult (11 years +), plaster.
• Q4018 - Cast supplies, long arm splint, adult (11 years +), fiberglass.
• Q4019 - Cast supplies, long arm splint, pediatric (0-10 years), plaster.
• Q4020 - Cast supplies, long arm splint, pediatric (0-10 years), fiberglass.
• Q4021 - Cast supplies, short arm splint, adult (11 years +), plaster.
• Q4022 - Cast supplies, short arm splint, adult (11 years +), fiberglass.
• Q4023 - Cast supplies, short arm splint, pediatric (0-10 years), plaster.
• Q4024 - Cast supplies, short arm splint, pediatric (0-10 years), fiberglass.
• Q4025 - Cast supplies, hip spica (one or both legs), adult (11 years +), plaster.
• Q4026 - Cast supplies, hip spica (one or both legs), adult (11 years +), fiberglass.
• Q4027 - Cast supplies, hip spica (one or both legs), pediatric (0-10 years), plaster.
• Q4028 - Cast supplies, hip spica (one or both legs), pediatric (0-10 years), fiberglass.
• Q4029 - Cast supplies, long leg cast, adult (11 years +), plaster.
• Q4030 - Cast supplies, long leg cast, adult (11 years +), fiberglass.
• Q4031 - Cast supplies, long leg cast, pediatric (0-10 years), plaster.
• Q4032 - Cast supplies, long leg cast, pediatric (0-10 years), fiberglass.
• Q4033 - Cast supplies, long leg cylinder cast, adult (11 years +), plaster.
• Q4034 - Cast supplies, long leg cylinder cast, adult (11 years +), fiberglass.
• Q4035 - Cast supplies, long leg cylinder cast, pediatric (0-10 years), plaster.
• Q4036 - Cast supplies, long leg cylinder cast, pediatric (0-10 years), fiberglass.
• Q4037 - Cast supplies, short leg cast, adult (11 years +), plaster.
• Q4038 - Cast supplies, short leg cast, adult (11 years +), fiberglass.
• Q4039 - Cast supplies, short leg cast, pediatric (0-10 years), plaster.
• Q4040 - Cast supplies, short leg cast, pediatric (0-10 years), fiberglass.
• Q4041 - Cast supplies, long leg splint, adult (11 years +), plaster.
• Q4042 - Cast supplies, long leg splint, adult (11 years +), fiberglass.
• Q4043 - Cast supplies, long leg splint, pediatric (0-10 years), plaster.
• Q4044 - Cast supplies, long leg splint, pediatric (0-10 years), fiberglass.
• Q4045 - Cast supplies, short leg splint, adult (11 years +), plaster.
• Q4046 - Cast supplies, short leg splint, adult (11 years +), fiberglass.
• Q4047 - Cast supplies, short leg splint, pediatric (0-10 years), plaster.
• Q4048 - Cast supplies, short leg splint, pediatric (0-10 years), fiberglass.
• Q4049 - Finger splint, static.
• Q4050 - Cast supplies, for unlisted types and materials of casts.
• Q4051 - Splint supplies, miscellaneous (includes thermoplastics, strapping, fasteners, padding and other supplies).
• Q4074 - Iloprost, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, up to 20 micrograms.
• Q4081 - Injection, epoetin alfa, 100 units (for esrd on dialysis).
• Q4082 - Drug or biological, not otherwise classified, part b drug competitive acquisition program (cap).
• Q4100 - Skin substitute, not otherwise specified.
• Q4101 - Apligraf, per square centimeter.
• Q4102 - Oasis wound matrix, per square centimeter.
• Q4103 - Oasis burn matrix, per square centimeter.
• Q4104 - Integra bilayer matrix wound dressing (bmwd), per square centimeter.
• Q4105 - Integra dermal regeneration template (drt) or integra omnigraft dermal regeneration matrix, per square centimeter.
• Q4106 - Dermagraft, per square centimeter.
• Q4107 - Graftjacket, per square centimeter.
• Q4108 - Integra matrix, per square centimeter.
• Q4110 - Primatrix, per square centimeter.
• Q4111 - Gammagraft, per square centimeter.
• Q4112 - Cymetra, injectable, 1 cc.
• Q4113 - Graftjacket xpress, injectable, 1 cc.
• Q4114 - Integra flowable wound matrix, injectable, 1 cc.
• Q4115 - Alloskin, per square centimeter.
• Q4116 - Alloderm, per square centimeter.
• Q4117 - Hyalomatrix, per square centimeter.
• Q4118 - Matristem micromatrix, 1 mg.
• Q4119 - Matristem wound matrix, per square centimeter.
• Q4120 - Matristem burn matrix, per square centimeter.
• Q4121 - Theraskin, per square centimeter.
• Q4122 - Dermacell, per square centimeter.
• Q4123 - Alloskin rt, per square centimeter.
• Q4124 - Oasis ultra tri-layer wound matrix, per square centimeter.
• Q4125 - Arthroflex, per square centimeter.
• Q4126 - Memoderm, dermaspan, tranzgraft or integuply, per square centimeter.
• Q4127 - Talymed, per square centimeter.
• Q4128 - Flex hd, allopatch hd, or matrix hd, per square centimeter.
• Q4129 - Unite biomatrix, per square centimeter.
• Q4130 - Strattice tm, per square centimeter.
• Q4131 - Epifix or epicord, per square centimeter.
• Q4132 - Grafix core and grafixpl core, per square centimeter.
• Q4133 - Grafix prime, grafixpl prime, stravix and stravixpl, per square centimeter.
• Q4134 - Hmatrix, per square centimeter.
• Q4135 - Mediskin, per square centimeter.
• Q4136 - Ez-derm, per square centimeter.
• Q4137 - Amnioexcel, amnioexcel plus or biodexcel, per square centimeter.
• Q4138 - Biodfence dryflex, per square centimeter.
• Q4139 - Amniomatrix or biodmatrix, injectable, 1 cc.
• Q4140 - Biodfence, per square centimeter.
• Q4141 - Alloskin ac, per square centimeter.
• Q4142 - Xcm biologic tissue matrix, per square centimeter.
• Q4143 - Repriza, per square centimeter.
• Q4145 - Epifix, injectable, 1 mg.
• Q4146 - Tensix, per square centimeter.
• Q4147 - Architect, architect px, or architect fx, extracellular matrix, per square centimeter.
• Q4148 - Neox cord 1k, neox cord rt, or clarix cord 1k, per square centimeter.
• Q4149 - Excellagen, 0.1 cc.
• Q4150 - Allowrap ds or dry, per square centimeter.
• Q4151 - Amnioband or guardian, per square centimeter.
• Q4152 - Dermapure, per square centimeter.
• Q4153 - Dermavest and plurivest, per square centimeter.
• Q4154 - Biovance, per square centimeter.
• Q4155 - Neoxflo or clarixflo, 1 mg.
• Q4156 - Neox 100 or clarix 100, per square centimeter.
• Q4157 - Revitalon, per square centimeter.
• Q4158 - Kerecis omega3, per square centimeter.
• Q4159 - Affinity, per square centimeter.
• Q4160 - Nushield, per square centimeter.
• Q4161 - Bio-connekt wound matrix, per square centimeter.
• Q4162 - Woundex flow, bioskin flow, 0.5 cc.
• Q4163 - Woundex, bioskin, per square centimeter.
• Q4164 - Helicoll, per square centimeter.
• Q4165 - Keramatrix, per square centimeter.
• Q4166 - Cytal, per square centimeter.
• Q4167 - Truskin, per square centimeter.
• Q4168 - Amnioband, 1 mg.
• Q4169 - Artacent wound, per square centimeter.
• Q4170 - Cygnus, per square centimeter.
• Q4171 - Interfyl, 1 mg.
• Q4172 - Puraply or puraply am, per square centimeter.
• Q4173 - Palingen or palingen xplus, per square centimeter.
• Q4174 - Palingen or promatrx, 0.36 mg per 0.25 cc.
• Q4175 - Miroderm, per square centimeter.
• Q4176 - Neopatch, per square centimeter.
• Q4177 - Floweramnioflo, 0.1 cc.
• Q4178 - Floweramniopatch, per square centimeter.
• Q4179 - Flowerderm, per square centimeter.
• Q4180 - Revita, per square centimeter.
• Q4181 - Amnio wound, per square centimeter.
• Q4182 - Transcyte, per square centimeter.
• Q4183 - Surgigraft, per square centimeter.
• Q4184 - Cellesta, per square centimeter.
• Q4185 - Cellesta flowable amnion (25 mg per cc); per 0.5 cc.
• Q4186 - Epifix, per square centimeter.
• Q4187 - Epicord, per square centimeter.
• Q4188 - Amnioarmor, per square centimeter.
• Q4189 - Artacent ac, 1 mg.
• Q4190 - Artacent ac, per square centimeter.
• Q4191 - Restorigin, per square centimeter.
• Q4192 - Restorigin, 1 cc.
• Q4193 - Coll-e-derm, per square centimeter.
• Q4194 - Novachor, per square centimeter.
• Q4195 - Puraply, per square centimeter.
• Q4196 - Puraply am, per square centimeter.
• Q4197 - Puraply xt, per square centimeter.
• Q4198 - Genesis amniotic membrane, per square centimeter.
• Q4200 - Skin te, per square centimeter.
• Q4201 - Matrion, per square centimeter.
• Q4202 - Keroxx (2.5g-cc), 1cc.
• Q4203 - Derma-gide, per square centimeter.
• Q4204 - Xwrap, per square centimeter.
• Q4 - Service for ordering-referring physician qualifies as a service exemption.
• Q5001 - Hospice or home health care provided in patient's home-residence.
• Q5002 - Hospice or home health care provided in assisted living facility.
• Q5003 - Hospice care provided in nursing long term care facility (ltc) or non-skilled nursing facility (nf).
• Q5004 - Hospice care provided in skilled nursing facility (snf).
• Q5005 - Hospice care provided in inpatient hospital.
• Q5006 - Hospice care provided in inpatient hospice facility.
• Q5007 - Hospice care provided in long term care facility.
• Q5008 - Hospice care provided in inpatient psychiatric facility.
• Q5009 - Hospice or home health care provided in place not otherwise specified (nos).
• Q5010 - Hospice home care provided in a hospice facility.
• Q5101 - Injection, filgrastim-sndz, biosimilar, (zarxio), 1 microgram.
• Q5102 - Injection, infliximab, biosimilar, 10 mg.
• Q5103 - Injection, infliximab-dyyb, biosimilar, (inflectra), 10 mg.
• Q5104 - Injection, infliximab-abda, biosimilar, (renflexis), 10 mg.
• Q5105 - Injection, epoetin alfa, biosimilar, (retacrit) (for esrd on dialysis), 100 units.
• Q5106 - Injection, epoetin alfa, biosimilar, (retacrit) (for non-esrd use), 1000 units.
• Q5107 - Injection, bevacizumab-awwb, biosimilar, (mvasi), 10 mg.
• Q5108 - Injection, pegfilgrastim-jmdb, biosimilar, (fulphila), 0.5 mg.
• Q5109 - Injection, infliximab-qbtx, biosimilar, (ixifi), 10 mg.
• Q5110 - Injection, filgrastim-aafi, biosimilar, (nivestym), 1 microgram.
• Q5 - Service furnished under a reciprocal billing arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area.
• Q6 - Service furnished under a fee-for-time compensation arrangement by a substitute physician or by a substitute physical therapist furnishing outpatient physical therapy services in a health professional shortage area, a medically underserved area, or a rural area.
• Q7 - One class a finding.
• Q8 - Two class b findings.
• Q9950 - Injection, sulfur hexafluoride lipid microspheres, per ml.
• Q9951 - Low osmolar contrast material, 400 or greater mg-ml iodine concentration, per ml.
• Q9953 - Injection, iron-based magnetic resonance contrast agent, per ml.
• Q9954 - Oral magnetic resonance contrast agent, per 100 ml.
• Q9955 - Injection, perflexane lipid microspheres, per ml.
• Q9956 - Injection, octafluoropropane microspheres, per ml.
• Q9957 - Injection, perflutren lipid microspheres, per ml.
• Q9958 - High osmolar contrast material, up to 149 mg-ml iodine concentration, per ml.
• Q9959 - High osmolar contrast material, 150-199 mg-ml iodine concentration, per ml.
• Q9960 - High osmolar contrast material, 200-249 mg-ml iodine concentration, per ml.
• Q9961 - High osmolar contrast material, 250-299 mg-ml iodine concentration, per ml.
• Q9962 - High osmolar contrast material, 300-349 mg-ml iodine concentration, per ml.
• Q9963 - High osmolar contrast material, 350-399 mg-ml iodine concentration, per ml.
• Q9964 - High osmolar contrast material, 400 or greater mg-ml iodine concentration, per ml.
• Q9965 - Low osmolar contrast material, 100-199 mg-ml iodine concentration, per ml.
• Q9966 - Low osmolar contrast material, 200-299 mg-ml iodine concentration, per ml.
• Q9967 - Low osmolar contrast material, 300-399 mg-ml iodine concentration, per ml.
• Q9968 - Injection, non-radioactive, non-contrast, visualization adjunct (e.g., methylene blue, isosulfan blue), 1 mg.
• Q9969 - Tc-99m from non-highly enriched uranium source, full cost recovery add-on, per study dose.
• Q9970 - Injection, ferric carboxymaltose, 1mg.
• Q9972 - Injection, epoetin beta, 1 microgram, (for esrd on dialysis).
• Q9973 - Injection, epoetin beta, 1 microgram, (non-esrd use).
• Q9974 - Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg.
• Q9975 - Injection, factor viii fc fusion protein (recombinant), per iu.
• Q9976 - Injection, ferric pyrophosphate citrate solution, 0.1 mg of iron.
• Q9977 - Compounded drug, not otherwise classified.
• Q9978 - Netupitant 300 mg and palonosetron 0.5 mg.
• Q9979 - Injection, alemtuzumab, 1 mg.
• Q9980 - Hyaluronan or derivative, genvisc 850, for intra-articular injection, 1 mg.
• Q9981 - Rolapitant, oral, 1 mg.
• Q9982 - Flutemetamol f18, diagnostic, per study dose, up to 5 millicuries.
• Q9983 - Florbetaben f18, diagnostic, per study dose, up to 8.1 millicuries.
• Q9984 - Levonorgestrel-releasing intrauterine contraceptive system (kyleena), 19.5 mg.
• Q9985 - Injection, hydroxyprogesterone caproate, not otherwise specified, 10 mg.
• Q9986 - Injection, hydroxyprogesterone caproate, (makena), 10 mg.
• Q9987 - Pathogen(s) test for platelets.
• Q9988 - Platelets, pheresis, pathogen-reduced, each unit.
• Q9989 - Ustekinumab, for intravenous injection, 1 mg.
• Q9991 - Injection, buprenorphine extended-release (sublocade), less than or equal to 100 mg.
• Q9992 - Injection, buprenorphine extended-release (sublocade), greater than 100 mg.
• Q9993 - Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg.
• Q9994 - In-line cartridge containing digestive enzyme(s) for enteral feeding, each.
• Q9995 - Injection, emicizumab-kxwh, 0.5 mg.
• Q9 - One class b and two class c findings.
• QA - Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is less than 1 liter per minute (lpm).
• QB - Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts exceeds 4 liters per minute (lpm) and portable oxygen is prescribed.
• QC - Single channel monitoring.
• QD - Recording and storage in solid state memory by a digital recorder.
• QE - Prescribed amount of stationary oxygen while at rest is less than 1 liter per minute (lpm).
• QF - Prescribed amount of stationary oxygen while at rest exceeds 4 liters per minute (lpm) and portable oxygen is prescribed.
• QG - Prescribed amount of stationary oxygen while at rest is greater than 4 liters per minute (lpm).
• QH - Oxygen conserving device is being used with an oxygen delivery system.
• QJ - Services-items provided to a prisoner or patient in state or local custody, however the state or local government, as applicable, meets the requirements in 42 cfr 411.4 (b).
• QK - Medical direction of two, three, or four concurrent anesthesia procedures involving qualified individuals.
• QL - Patient pronounced dead after ambulance called.
• QM - Ambulance service provided under arrangement by a provider of services.
• QN - Ambulance service furnished directly by a provider of services.
• QP - Documentation is on file showing that the laboratory test(s) was ordered individually or ordered as a cpt-recognized panel other than automated profile codes 80002-80019, g0058, g0059, and g0060..
• QQ - Ordering professional consulted a qualified clinical decision support mechanism for this service and the related data was provided to the furnishing professional.
• QR - Prescribed amounts of stationary oxygen for daytime use while at rest and nighttime use differ and the average of the two amounts is greater than 4 liters per minute (lpm).
• QS - Monitored anesthesia care service.
• QT - Recording and storage on tape by an analog tape recorder.
• QW - Clia waived test.
• QX - Crna service: with medical direction by a physician.
• QY - Medical direction of one certified registered nurse anesthetist (crna) by an anesthesiologist.
• QZ - Crna service: without medical direction by a physician.

HCPCS codes
HCPCS codes starting with A - B - C - D - E - F - F - G - H - I - J - K - L - M - N - O - P - Q - R - S - T - U - V - W - X - Y - Z

External links

• HCPCS by the AAPC
• HCPCS Complete Reference
• HCPCS Level 2 codes 2020